Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
14/10/2026 16:00
BRIEF-Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue Oct 14 (Reuters) - Laurus Labs Ltd LAUL.NS:
LAURUS LABS - INVESTS 1.08 BILLION RUPEES INTO KRKA PHARMA VIA RIGHTS ISSUE
Source text: ID:nnAZN4TOXWT
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig